Israel’s AEYE Health (reported here previously) is pushing hard to get its retinal disease AI diagnostic eye scanner approved by the end of 2020. The Covid-19 pandemic has seriously cut the number of patients visiting eye specialists. The eye scanner … Continue reading →

Israeli biotech Mileutis has developed Imilac – designed to treat mastitis in cows by boosting their immune systems. Imilac is near the marketing stage and can replace the wide use of antibiotics for which resistance is growing and being passed … Continue reading →

Nanotechnologists at Israel’s Technion Institute have eliminated the time-consuming amplification process in coronavirus and secondary cancer tests. 100 molecules of the sample are passed one by one through a nanopore – a tiny hole and assessed for the presence of … Continue reading →

Israel’s Adasky (reported here previously) develops and manufactures high-resolution thermal vision AI sensors for the advanced vehicle industry. Its Viper-R system can detect Covid-19 instantly, by scanning multiple individuals 10 meters away for elevated body temperatures. https://www.calcalistech.com/ctech/articles/0,7340,L-3864150,00.html

Israel’s NextGen Biomed is developing a breathalyzer test (see another here) to identify Covid-19 infections. The biological markers were identified in an April study by Israel’s Scentech Medical. The two companies are now being merged and a validation trial is … Continue reading →

Israel Aidoc’s triaging and notification algorithms for flagging and reporting incidental pulmonary embolism (see here) have just been approved by the US FDA.  The solution is an ‘always-on’ safety net for unexpected cases. It is Aidoc’s sixth FDA-approved tool for … Continue reading →

Ziv Medical Center in Tzfat (Safed) will be the first Israeli hospital to use drones. They will transport medical equipment, medicines, and blood and Corona tests, to and from the hospital. Initially, they will carry 5kg loads up to 10km, … Continue reading →

Israel’s Kamada (reported here previously) has signed a deal to supply Israel’s Health ministry with its plasma-based hyperimmune immunoglobulin (IgG) product. The product treats COVID-19 patients with pneumonia and is currently in Phase 1 & 2 trials in Israel. https://nocamels.com/2020/10/kamada-deal-supply-israel-health-ministry-covid-19-antibody/ … Continue reading →